Dose Ranging Study in Healthy Methadone Maintenance Subjects

Phase 1

Completed

• Conditions: Adult

• Registration Number: NCT00387491
• Lead Sponsor: Bausch Health Americas, Inc.

Brief Summary

To assess the effect of a single oral dose of MOA-728, an investigational drug, on the oral-cecal transit time in subjects who are taking methadone.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-06
• Primary Completion: 2006-10
• Study Completion: 2006-10
• Study First Submitted: 2006-10-11
• Study First Submitted QC: 2006-10-11
• Study First Posted: 2006-10-13
• Status Verified: 2019-11
• Last Update Submitted: 2019-11-21
• Last Update Posted: 2019-11-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Primary Outcome Measures

Name	Time	Method
Oral-cecal transit time will be evaluated.